UNSPSC 51373403: Acetaminophen/chlorpheniramine/codeine/phenylephrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51373403 Acetaminophen/chlorpheniramine/codeine/phenylephrine is a Commodity code, but the recent state and local solicitations tagged under it diverge significantly from its nominal scope — the code does not represent the work actually being bought. The Washington State Department of Corrections RFQ (RFQQK13020) solicits parenteral products, services, and equipment including parenteral nutrition solutions, intravenous solutions, and controlled substances for incarcerated individuals, with no mention of the specific acetaminophen-chlorpheniramine-codeine-phenylephrine formulation the code names. The Seminole County, Florida IFB (IFB60459723LAS) seeks naloxone and drug deactivation systems for community health initiatives, which is similarly unrelated to the code's stated product. The mismatch suggests either persistent tagging errors or that state and local procurement offices are using this code as a catch-all for pharmaceutical and medical supply categories broader than the specific formulation intended.

State and local issuing bodies posting under this code include state correctional agencies and county public health departments. Geographic activity centers on Washington State and Florida based on recent postings. The Washington State Department of Corrections opportunity (due October 7, 2026) involves supplying eight correctional facilities across three regions with parenteral products under a multi-year contract beginning November 26, 2026, with set-aside aspirations for small, minority-owned, women-owned, and veteran-owned businesses and encouragement of subcontractor inclusion plans; DOC anticipates awarding up to three contractors per region. The Seminole County opportunity carries an outdated due date (July 26, 2023) but documents an annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries and a two-year initial term plus one-year renewal option. Bidders on both opportunities must meet state licensure, background clearance, and insurance requirements specific to each jurisdiction.